Ahead of and during the hearings in Washington on Wednesday, Louisiana Republican Sen. Bill Cassidy navigated a narrow path between his role as a member of Congress overseeing the Health and Human Services department and his position in a tight intraparty political fight at home. In questioning Health Secretary Robert F. Kennedy Jr., Cassidy targeted vaccine policy changes that Kennedy has pursued and that have helped make vaccine-preventable diseases such as measles part of the public debate.
Cassidy’s approach drew attention because the senator is also a practicing physician. The Associated Press reported that Cassidy chairs one Senate committee that oversees Kennedy’s department and sits on another, and that in the Wednesday hearings he asked about topics that ranged from affordability and alleged fraud to abortion drugs and the prospect of disease outbreaks.
A central theme in Cassidy’s questioning was vaccine confidence and how the administration plans for outbreaks. Cassidy noted that trust in vaccines has declined in the U.S. over the past year and asked Kennedy how he would address expected outbreaks of vaccine-preventable diseases tied to upcoming events including the World Cup and “America 250.”
Cassidy also spoke in medical terms about the consequences he said he has personally seen. The AP reported that Cassidy told Kennedy, “I am a doctor who has seen people die from vaccine preventable diseases,” and added that when outbreaks number in the thousands and people—including children—die again from vaccine-preventable diseases, “it seems more than tragic.”
Outside the hearing room, political and academic assessments pointed to an electoral risk for a senator who takes visible responsibility for questioning a cabinet-level official in his own party. Claire Leavitt, an assistant professor at Smith College who studies congressional oversight, said Cassidy had taken “a risk showing any sort of resistance to RFK” and “He may pay an electoral price for that.”
At the same time, Cassidy’s questioning also reflected an effort to keep his distance from the vaccine policy agenda associated with Kennedy. The AP reported that Cassidy has spent years as a physician advocating for vaccinations, including support for babies receiving hepatitis B vaccines shortly after birth, while Kennedy has moved to dramatically roll back childhood vaccine recommendations. Cassidy supported Kennedy’s nomination last year only after receiving commitments that, according to the report, included Kennedy working within the current vaccine approval and safety monitoring system and supporting the childhood vaccine schedule.
Cassidy’s political constraints tightened against that backdrop. The AP reported that President Donald Trump endorsed one of Cassidy’s primary opponents in Louisiana, Julia Letlow, as an unusual attempt to unseat a sitting Republican senator from within the party. The report also described Cassidy as facing opposition from Kennedy’s allies in the “Make America Healthy Again” movement, including the MAHA PAC, which has pledged $1 million to Letlow’s campaign.
Kennedy’s allies also press Cassidy with questions about his own stance toward the administration. The AP reported that Cassidy told reporters earlier this month, “I’m not really sure what MAHA’s beef is,” and added, “Let me point out that I am the reason that Robert F. Kennedy is now the secretary of HHS. He would not have gotten there otherwise.” The report said Cassidy argued that he has “strongly supported” the MAHA agenda, including a fight against ultraprocessed foods, while acknowledging that he and MAHA “disagreed on vaccines.”
In the Wednesday hearings, Cassidy’s medical and oversight posture also prompted assessments from consultants about how to read his tactics with voters. Mary-Patricia Wray, a Louisiana political consultant, compared Cassidy’s approach to a “polite ‘I told you so.’” She said Cassidy reinforced “the real-world consequences of declining vaccine confidence” while signaling the administration was moving toward a stance closer to Cassidy’s as a physician.
Experts said the political cost of Cassidy’s vaccine-focused scrutiny may not be as high with Republicans as some consultants assume. Dorit Reiss, a vaccine law expert at UC Law San Francisco, said Cassidy’s approach might not alienate voters and noted that the report said Kennedy and the Trump administration have recently shifted away from discussing vaccines directly, focusing instead on issues such as healthy eating.
Reiss and others also highlighted what Congress oversees when it challenges a cabinet official in public. The AP reported that Reiss said Cassidy’s earlier record left room for stronger action, while another expert, Claire Leavitt, said seniority often determines who chairs Senate committees and that a different Republican may be less willing to check Kennedy’s power if Cassidy does not advance to November’s general election.
Cassidy also used the Wednesday hearings to probe Kennedy on issues that extend beyond vaccines. The AP reported that Cassidy asked Kennedy why the department had not reinstated an in-person dispensing requirement for chemical abortion drugs, and framed that line of questioning as a way to court Republicans beyond the MAHA-aligned bloc.
The AP described the broader stakes as both political and procedural: Cassidy’s reelection would affect what happens next in his oversight role as chair of the Senate Health, Education, Labor and Pensions committee and the committee’s ability to scrutinize the health department’s agenda.